let's get down to meg tirrell who has that for you. >> w.h.o.as meeting for the second day, public health emergency of international concern. the word coming down, now is not the time it's a bit too early to consider this event that strong right now. they've only declared this five other times since 2005, including the two ebola outbreaks. essentially they said the committee was split down the middle whether to declare this a public emergency of health concern. potential severity and number of cases, half say, do warrant the concern. the other half says china is try taking moves to try to limit that spread. they're asking china continue to be transparent about information about the number of cases and everything else about the virus. brian, right now, not meeting that designation back to you. >> meg tirrell with that breaking news. thank you very much. >>> a lot happening in this hour, as you can tell. here is what else is coming up on "the exchange". >> announcer: ahead, ge's rally. grubhub rolls out a new strategy l brands continues to get lot

and phil le beau with comments from the new ceo and meg tirrell with the latest on the mysterious coronavirus and it is spreading in china and it is hitting our shores here. "power lunch" starts right now. >>> good day, i'm contessa brewer, let's get right to it with boeing recovering after being down more than 3%. phil lebeau is following the twist and turns, what do you have. >> the reason they are rebounding is because ceo just wrapped up a conference call and said we're not cutting the dividend or scrapping the max, we still believe in it the questions that he received revolved around the latest time frame from the company saying it is mid 2020 when we expected the ungrounding by the regulators and why did they make that change here is calhoun talking about it. >> our customers who have really important fleet planning decisions to make, all of whom have reached out to me over the last couple of months to tell me that it's getting to be impossible can we please have something that we have a little more confident in and as you might imagine that has something to do with the new schedule. >>

a news alert on the pharma company incite meg tirrell has more >> reporter: we're seeing incyte move to the downside a trial failed to meet its primary goal the disease is essentially an immune reaction that can happen after a stem cell reaction you're seeing incyte down 10%, quite a sizable move on this, unfortunately disappointing news >> meg tirrell, thanks very much we'll talk more about biotech in the hour >>> switching gears, shares of tesla revving higher today after the company says it's gearing up for the year the rush to electric vehicles is being predicted to push tesla's stock price to the highest target on the street we just heard from the analyst behind that big call here is how he justified the $515 target. >> if we look at the momentum coming into this year we see several positive factors we frankly didn't have last year. when we look at that and we kind of add up what they're going to be introducing, and the fact that many of the bear signals are not there this year, that's really what gives us our bullish stance >> karen, what should i do with tesla, buy it, hold it

breaking in the last hour on the corona virus here in the u.s., meg tirrell is in terry town, new york eunice yoon is in beijing, where the numbers continue to climb. meg, let's start with the latest on this human-to-human transmission in the united states. >> reporter: that's right, tyler. cdc confirmed the first human-to-human transmission, the spouse of the confirmed patient in chicago the original patient had traveled from wuhan, china, back to the united states january 13th and lived with her spouse and he has now been confirmed with the novel coronavirus cdc and health officials in illinois saying they were very close contacts living together and do not believe there's a risk to the broader american public they're not making a recommendation that people in chicago change their behavior, cancel their activities in the community. the cdc said more broadly that they don't make recommendations that people wear face masks. they don't generally recommend people do that in cold and flu season even though we are in cold and flu season right now. this brings the total number of confirmed

so let's bring in meg tirrell for the latest meg? >> hey, seema. health officials suspect there will be more cases here in the united states after they confirmed that second one just this morning 63 cases have been under investigation by the cdc from 22 states, and in addition to the two confirmed positive here, they found 11 to be negative for the virus. now, health researchers say they're still learning about the nature of the virus. while it's in the same family of coronaviruss as sars and mrs, cdc officials are hesitant to make comparisons in terms of severity or its speed of spread. right now they believe the immediate risk to the u.s. public is low, though they note that the situation is evolving meanwhile, case counts keep rising in china with the global total reaching 937 with confirmed deaths at 26 and cases in nearby countries are also mounting and within china, more cities now having travel restricted, covering a total, guys, of 46 million people. >> somebody on twitter asked a pretty good question it's very, very basic, though. a lot mo

. >>> the biggest health care investing event kicking off today in san francisco meg tirrell is therehe jp morgan health care conference with the ceo of regeneron. it is all yours. >> scott thank you so much dr. lynch lifer thank you for joining us today. >> great to be here. >>> want to talk about your trug for age related macular degeneration you have gotten new competition from novartis. some folks are trying to decifer what that's going to mean. somebody said that could take half the market from you tell us about the future of that drug. >> we announced that the drug had a great quarter. it did $1.22 billion in the united states. that was no impact of inventory. that was the first quarter which this new product was competing with us. that represented year over year growth, double digits of 13 or 14% for the year, which is pretty remarkable for a drug of that size. so we see a lot of opportunity for that drug to continue to grow there is always going to be competition. we have faced competition from many companies, on this dug. but we have a safety profile that i think is remarkabl

you. >> thank you, doctor we are now ready to take questions. >> all right let's get now back to meg tirrelistening to the director of the national center for immunization and respiratory diseases meg, what did we learn about where this is now and the further steps that are being taken here in the u.s. >> a few important things popped out from that call just now. one, we don't have any new cases yet confirmed in the united states the count is still five. they have a new additional samples they are testing, up to 110, but they've confirmed more negatives, 32 negatives up from 25 yesterday they also started the call out by talking about diagnostic tests. that's important dr. scott t gottlieb, former commissioner, wrote an op-ed on cnbc.com talking about the importance of getting rapid testing at the point of care so right now, samples have to be sent to the cdc dto be confirme. they are trying to get their tests out to states and hopefully even more broadly once they've confirmed that these tests work well in order for people to be able to test and get those results back quickly gottlieb in t

meg tirrell joins us as pharmaceutical companies race for a cure meg?> work is under way at a number of pharmaceutical companies. while some are screaming existing antiviral drugs to see if they work against the coronavirus, other companies are working to develop new drugs one has a variety of antibodies derived from the blood of survivors of sars. those people's immune cells created antibodies to that virus and veer has sortd through to find the strongest candidates to help treat disease they're screening those antib y antibodies to see if it will work with this virus at regeneron, they're taking a similar approach, only they have a technology that allows them to use mice with human immune systems to create antibodies that sounds crazy but they've genetically engineered mice to replace their own immune systems with human ones. they can select the best antibody the-bodies they createn response >> these are essentially microhumans and you infect them with the virus and select out for the mice that have now made a human response, clone it out of these mic

beyond fast. >>> let's get back to meg tirrell now.he has another update regarding the coronavirus as she listens to the cdc call. >> more details on the first human to human transmission in the united states of the novel coronavirus. this patient is the spouse of the original patient in chicago who had travelled back from wuhan, china, on january 13th. obviously a very close contact the husband of that patient. they say they are tracking all of their close contacts, including health care workers. that is the public health response there to try to further contain this and public health officials are being very careful to say they do not think there is a broader risk of this spreading in the community. they say to people of chicago, where these folks live, that they are not making any recommendations as to cancelling plans or activities, saying that this is not spreading in the broader community, guys. this is the spouse of that patient who had travelled back from wuhan, china. we will bring you any more scott as we get it. >> important

that's meg tirrell covering that stock. we mentioned stocks down today estee lauder is one of them.ded today at oppenheimer. also off of their top picks list talking about the krin affecting their travel related sector. >> if you like the company for the fundamentals and you have looked at it and you anticipate that you are looking to trade in and out of the stock over the next couple of months then i could see the downgrade here i think longer term you are not going to see a meaningful impact in that the acceleration of potential earnings in this particular stock is going to continue despite the fact that there might be near term disruption in the name. >> can you step in to.a wynner an lvs today. >>> wouldn't step in on a casino. >> another one that got downgrade of the at b of a coronavirus the headline for the reason why. >> we own sands. we bought it in june of last year on expectations of acceleration in the chinese economy as well as a shift from vip gaming into retail gaming. i think that that second piece, i do think that the reacceleration of the chinese economy is going t

. >>> let's bring in meg tirrell with with a look at the pharmaceutical response. >> companies are moving quickly. they're also looking into developing new drugs and rapidly working to develop vaccine we went into the lab of mo derna to learn move about the approach they have identified the proteins on the virus they'll target with the vaccine. they say they've got working nights and weekends to ramp up a phase one clinical trial they hope to do that in a few months if that's successful, the next challenge is to increase manufacturing capability. >> we're all hopeful that it's not a situation that evolves, but unfortunately hope is not a strategy what we need to be doing right now is putting our head down, working around the clock to make sure if it does evolve, there's a chance for us to intervene and hopefully slow the spread of this virus. >> that's what you're hearing from all they countries, hoping for the best, but as you just heard there, hope is not a strategy wilf >> meg, thank you. >>> let's get over to seema for a look at the stocks that are moving the most. >> the conversation

meg tirrell, you are most america's most well-loved and well-liked sort of pharmacy and biotech reporter think i'm the only one on television but i'll take it. >> women face a lot more crap, for lack of a better term, than guys do. i imagine you're in favor of this feature. >> actually, i'm not. >> no? >> when they're talking about the health of public conversation, i think there are two ways to read into that the health meaning, yes, let's get rid of people who are trolling and can be even more damaging some of these things are disgust i ing. and i mute or block those people but the health of public discourse means that people should be able to engage even if the person posting doesn't agree with that. let's think about if president trump only allowed his followers to engage with his tweets. that means the only things he sees are people who already agree with him. >> whenever you muddle into this free speech debate i kind of agree with you but i also worry, robert, there's a lot of bots out there. you look at replies on certain things it's the same language those are not people those ar

meg tirrell who has been working over time this week. thank you. next couple of hours will be eventful as we pivot to the fed and facebook, microsoft, tesla tonight. >> quite a bit. >> let's get back to the judge and "the half. >> i'm scott wapner. front and center, apple aftermath. how the most valuable company on earth might have just saved the market it is 12:00 noon, and this is "the half time report". >> announcer: apple hitting all-time highs on blockbuster results. the number one apple analyst on the street tells us where the stock goes from here the other trillion dollar dow stock, microsoft, getting ready to report after the bell the traders take their position. ge having its best day in more than a year on the back of its numbers. boeing soaring, mcdonald's rallying how to trade them from here. and facebook getting a big upgrade ahead of its earnings today. it's our call of the day the investment committee is ready to go. "half time report" starts right now. >> welcome to post nine at the new york stock exchange. great to have you with us

. >>> the biggest health care investing event is taking place in san francisco right now meg tirrell live at the jp morgan health care conference with the ceo of high flying sarepta therapeutics meg, it is all you. >> scott, thank you so much. doug ingram thank you for being here with us. >> thank you for having us appreciate it. >> of course the program that people are looking at closely with you is gene therapy for muscular dystrophy which could be trabs formative for this devastating disease. tell us about the standpoint for the investor standpoint and from the patient standpoint. >> we are derisking along the way. we still have a lot to do. to remoon you, we have a gene therapy for muscular dystrophy it relates to this disease that results in a lack of a protein which is a shock absorb they are the muscles. they are trying to literally insert into the muscles of these children significantly truncated but still functional version of that protein to try to keep them alive and keep them healthy. we had a really fascinating and very significantly impressive data on first four childre

meg tirrell who has been working over time this week. thank you. be eventful as we pivot to the fed and facebook, microsoft, tesla tonight. >> quite a bit. >> let's get back to the judge and "the half. >> i'm scott wapner. front and center, apple aftermath. how the most valuable company on earth might have just saved the market it is 12:00 noon, and this is "the half time report". >> announcer: apple hitting all-time highs on blockbuster results. the number one apple analyst on the street tells us where the stock goes from here the other trillion dollar dow stock, microsoft, getting ready to report after the bell the traders take their position. ge having its best day in more than a year on the back of its numbers. boeing soaring, mcdonald's rallying how to trade them from

and phil le beau with comments from the new ceo and meg tirrell with the latest on the mysterious coronavirus spreading in china and it is hitting our shores here. "power lunch

let's get to meg tirrell at cnbc hq. >> biotech may have been down but look at some of the stocks that again johnson & johnson. moderna, and vir they are all working on potentially attacking the coronavirus. the exception is regeneron, which is working on a potential drug but it closed down today about 1.7% these are not the smaller micro cap names that are volatile during outbreak headlines though analysts say some of the moves may be exaggerated johnson & johnson is the world's largest health care company and has experience creating vaccines we talked with paul stofls about their previous work and what it suggests for this time around. >> we have done this in ebola, in six months from having a construct virus to scaling it up and bringing it to humans. with zika we have done it in 12 months where we did not have the virus and we had to start from scratch. here here in the same situation as zika. we have from a sequence which we now know. >> looking into whether approved drugs for hiv is helpful against the coronavirus. smaller bioteches are also in the hunt this morning we visited th

let's get to meg tirrell she has a market flash on pfizer and just spoke with the company's ceo. >> igot off the phone with alert bore low, we talked about the fact that the company's 2020 guidance it provided this morning doesn't include any plans for buybacks thisser yo. the company saying they instead plan to invest in the company and he told me they want to invest in the business rather than quote treading water with buybacks we also talked about their business in china. pfizer has a r and d center in wuhan. he said they are monitoring the situation closely. they have closed their offices for a week, longer than the lunar new year they are using digital tools to stay in touch with all employees and they are closely monitoring all of their slys from china and they haven't seen threats to the supply chain or imminent disruptions. everybody is keeping an eye on that stock is down 4% as they did miss the q 4 eps >> i wonder what the investment community thinks about the new buybacks. >> they don't like it. >> well, the stock was already down the stock was already down on the miss i wo

. >>> meg tirrell has the latest details from the world health organization eunice is on the ground in beijing, and contessa is watching for the fallout casinos have a significant footprint in macau meg, let's start things off with you. and the word today is it's not yet the time the committee was split down the middle, but said the lack of the spread for nour contributed to the decision they want it's expected that further international exportation of cases may appear in any country, so all countries, they say, should be prepared for containment contessa >> thank you for that, meg, eunice yoon, what are you learning >> seven cities and 23 million people are effectively under quarantine the cities are clustered an wuhan. the residents have been told to stay at home at outdied trains, flights, no car-hailing apps, and the only way to get out is to drive in your car or face a taxi, if you do, you will face health checks along the way. the chinese government has been criticized for being slow to respond. it looks, though, as now that beijing is moving into overdrive. calling on companies

. >> you can't fit it next for the astin martin >>> meg tirrell has an update. >> boosted the stock ofppellate, that would settled back down since then it's a drug for a rare disease, which is also the tarik of alex on's 3.5 billion drug. it showed analysts point out that there are some potential safety concerns like injection site reactions that that think they could hinder the adoption guys, back to you. >> i'm going to stick with pnh quite a mouthful there >>> the internals a big of slippage that's not dramatic one way or another. pretty representative, i would point out, though, look at the five-day chart in fact, every day within the span, if you had the visit daze, you've had a low made in the morning right after the close. good es what today maybe finally too many people tried to make that 3we9 the low for the day on the s&p is 3232. we're just a few points above that right now obviously the market is a bit tired, trying to figure out if we need to come off the boil in terms of the sentiment. >> we've had a couple of those days led by selling internationally. not actually the ca

our meg tirrell is with us, and they join us. >>> would you doi think, in your words, this is a dumby, pricing has gone up far too much, but we're supposed to do it in an intelligent way you make crestor, you have to do the research to make a new drug, i don't care what the technology is, that's similar to lipitor. then you have to do the clinical development to make sure it connects approved. pricing becomes irrelevant and you're not doing what the industry is meant to do. right now, 50% of people who reach the will get alzheimer's what we are meant to do is change that we haven't done that, but we are meant to do it, now by disrupting, by telling old drugs at a discount. generics already do that people do have a lot of trouble affording their medicines, so if not this solution, what solution we have to price things when they work, now with incremental benefit. not when they were ten checkpoint antibodies on the market so payer can negotiate and make it fair. >> this company is saying a hey, maybe be will introduce new and undercut the competition then the competition will undersell

people infectioned around the world the coronavirus is now rising. 26 deaths have been recorded meg tirrell has the laters the eunice yoon is on the ground in beijin beijing. dana from telsy advisory group is here with us to talk about the possible impact on china-exposed stocks. >> reporter: comes out just now, the numbers are ticking higher health officials here in the u.s. confirmed this morning the second case here, a woman in chicago, who had traveled back from wuhan china early last week the cdc says 63 potentially cases have been under investigation from 22 states, in addition to the two confirmed positive, 11 were found negative for the novel coronavirus. they're working quickly to learn more, and they said they believe the immediate risk to the u.s. public is low, but note that the situation is evolving quickly. contessa >> thank you, meg. let's get to eunice yoon what are you finding out about china's respond? . >> reporter: well, china is now restricting travel for 16 cities, that's 46 million people, double the population of florida. the focus now is on whether the chinese gover

also our own meg tirrell director zeller, thanks for being with us. >> my pleasure. >> let's talk aboutan. how come in the end it did not include menthol? >> new data came in later in september from a futures survey which showed kids who are using flavored ecigarettes greatly preferred mint to menthol. >> dr. ann schushaf testified that in order for the flavored ban to workmen thol would have to be included what do you think of this? >> that was made before -- >> that you have to ask cdc. the position announced yesterday is to go after the flavors that are most popular with kids in the form that is most popular with kids, that is the so-called cartridge and pod-based products popularized by juul. >> it showed 5 million kids had used ecigarettes in the last month. a lot of kids are already using these. if mint goes away, how do you know they won't just switch to menthol? >> what we said in the guidance and our announcement yesterday is we have the ability to monitor and surveil what's going on and what the patterns of use are and we've made it clear that if kids migrate to the menthol, t